SHINE Medical Technologies, a Monona, Wisconsin-based medical isotope manufacturer, is now closer to producing molybdenum-99 (Mo-99) after receiving a new custom-designed production accelerator.

Among women receiving radiation therapy to treat early-stage breast cancer, receiving larger individual doses was not associated with a significant increase in long-term side effects, according to a 10-year study presented Oct. 21 at the American Society for Radiation Oncology (ASTRO) Annual Meeting in San Antonio, Texas.

TUSTIN, Calif.—At this year’s American Society of Radiation Oncology (ASTRO) annual meeting in San Antonio, Texas, October 21-24, 2018 (Booth #3737), Canon Medical Systems USA, Inc. will showcase its recently FDA-cleared Aquilion PrecisionTM, the world’s first Ultra-High Resolution CT system. The system can resolve anatomy as small as 150 microns and is designed to provide more than twice the CT resolution as standard systems. Containing an all-new detector as well as tube, gantry and reconstruction technologies, the system may make it possible to help expand visualization of disease thanks to new features that offer improved image detail.

A primer for practices that are now in discussions about merging, acquiring or otherwise consolidating—or may find themselves having “the talk” at some point in the not-distant future.

How best to participate in the pre-exam patient education process? Consider some tips from radiologists who take a proactive stance in the process.

Want to see consolidation in action? Look anywhere. Across the globe, mergers and acquisitions are upending the established order at a pace not seen since just before the entire U.S. economy went over the falls in 2008. One hopes the same doesn’t happen on the back end of the present M&A frenzy.

Research published in the Journal of the American Medical Association: Oncology debunked the widely accepted rule that cancer patients should not use topical skin treatments before radiation treatments.

Breast density notification laws were designed to motivate supplemental breast cancer screening among women at an increased risk. However, they have resulted in more low-risk women undergoing unnecessary supplemental screening, according to new research published in the Journal of the American College of Radiology.